Cas:51773-92-3 Mefloquine hydrochloride manufacturer & supplier

We serve Chemical Name:Mefloquine hydrochloride CAS:51773-92-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Mefloquine hydrochloride

Chemical Name:Mefloquine hydrochloride
CAS.NO:51773-92-3
Synonyms:Mefloquine hydrochloride;[2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol;EINECS 257-412-0;[2,8-bis(trifluoromethyl)quinolin-4-yl](piperidin-2-yl)methanol;4-quinolinemethanol, a-2-piperidinyl-2,8-bis(trifluoromethyl)-;[2,8-Bis(trifluoromethyl)-4-quinolinyl](2-piperidinyl)methanol;MFCD00797519;(AS)-rel-a-(2R)-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol monohydrochloride;4-Quinolinemethanol, α-2-piperidinyl-2,8-bis(trifluoromethyl)-;α-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol;Mefloquine (hydrochloride)
Molecular Formula:C17H17ClF6N2O
Molecular Weight:378.312
HS Code:

Physical and Chemical Properties:
Melting point:250-254ºC
Boiling point:415.7±40.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.519
PSA:45.15000
Exact Mass:378.116669
LogP:2.87

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3077 9 / PGIII
Packing Group:


Contact us for information like Mefloquine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Mefloquine (hydrochloride) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Mefloquine (hydrochloride) Use and application,[2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol technical grade,usp/ep/jp grade.


Related News: Other possible health risks of PFAS include kidney cancer, testicular cancer and high blood pressure, the researchers added. Mefloquine hydrochloride manufacturer The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. Mefloquine hydrochloride supplier Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.�� Mefloquine hydrochloride vendor Amanpour is based in London, and said she feels fortunate to have health insurance through work and incredible doctors who are treating me in a country underpinned by, of course, the brilliant NHS [National Health Service],” CNN reported.
“I want to applaud Christiane Amanpour for her candor, bravery and always working towards the greater good,” he said in a statement. “As a cancer survivor, I too encourage people to listen to their bodies and get all early cancer screenings available to them. Mefloquine hydrochloride factory Jo Soden, Co-managing Director of Retrogenix, said ��We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant��s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.��